These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6758585)

  • 1. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRD.
    Flynn JT; Kershaw DB; Sedman AB; Smoyer WE; Bunchman TE
    Adv Perit Dial; 1998; 14():265-8. PubMed ID: 10649738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy.
    Grefberg N; Danielson BG; Nilsson P
    Acta Med Scand; 1984; 215(5):427-34. PubMed ID: 6377827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
    Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
    Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes, intraperitoneal insulin, and CAPD.
    Cohen IM; Lee S
    Clin Exp Dial Apheresis; 1981; 5(3):269-75. PubMed ID: 7037250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of two different routes for insulin administration in CAPD diabetic patients. A multicenter study.
    Selgas R; Diez JJ; Muñoz J; Miranda B; de Alvaro F; Rodriguez JC
    Adv Perit Dial; 1989; 5():181-4. PubMed ID: 2577407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus.
    Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG
    Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of continuous ambulatory peritoneal dialysis in diabetic and nondiabetic patients.
    Flynn CT; Shadur CA
    Am J Kidney Dis; 1981 Jul; 1(1):15-23. PubMed ID: 7331998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
    N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis.
    Wu MS; Yu CC; Wu CH; Haung JY; Leu ML; Huang CC
    Perit Dial Int; 1999; 19 Suppl 2():S179-83. PubMed ID: 10406515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dialysis in diabetic end-stage renal disease.
    Khanna R; Oreopoulos DG
    J Diabet Complications; 1989; 3(1):12-7. PubMed ID: 2523400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2 year evaluation of diabetic patients on continuous ambulatory peritoneal dialysis.
    Coronel F; Naranjo P; Torrente J; Gallego E; Domingo C; Prats D; Barrientos A
    J Diabet Complications; 1987; 1(1):20-5. PubMed ID: 2968992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High peritoneal permeability predisposes to hepatic steatosis in diabetic continuous ambulatory peritoneal dialysis patients receiving intraperitoneal insulin.
    Nevalainen PI; Kallio T; Lahtela JT; Mustonen J; Pasternack AI
    Perit Dial Int; 2000; 20(6):637-42. PubMed ID: 11216552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
    Perit Dial Int; 1996; 16 Suppl 1():S288-91. PubMed ID: 8728209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement.
    Wong TY; Chan JC; Szeto CC; Leung CB; Li PK
    Am J Kidney Dis; 1999 Sep; 34(3):514-20. PubMed ID: 10469863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAPD and transplantation in diabetics.
    Passlick J; Grabensee B
    Clin Nephrol; 1988; 30 Suppl 1():S18-23. PubMed ID: 3052957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.